Skip to content
Home/Companies/Biotech/CatalYm
CA

CatalYm

Biotech·Germany·Active·4yr hold

CatalYm is a biotech company, headquartered in Germany.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns CatalYm?

CatalYm is currently owned by Jeito Capital through Jeito I (2021 vintage), since 2022. Across its history, CatalYm has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-05-13

Jeito Capital
Most recent investor
Jeito Capital
Jeito I · 2021 · VC
2 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by coparion and Jeito Capital since 2020.
Co-invest · 2 holders · 2020 · present
coparion
coparionActive
2020 · present · coparion · 2016 · VC
MOIC
–
Jeito Capital
Jeito CapitalActive
2022 · present · Jeito I · 2021 · VC
MOIC
–

More from Jeito I

Other portfolio companies in the same fund.

Corteria Pharmaceuticals
Active
BiotechFrance· 2023
Noema Pharma
Active
BiotechSwitzerland· 2023
Advesya
Active
BiotechSpain· 2022
CDR-Life
Active
BiotechSwitzerland· 2022
EyeBio
Exited 2024
BiotechUS· 2022
to
NMD Pharma
Active
BiotechDenmark· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings